Nazari, PMS; Riedl, J; Preusser, M; Posch, F; Thaler, J; Marosi, C; Birner, P; Ricken, G; Hainfellner, JA; Pabinger, I; Ay, C.
The combination of podoplanin expression levels and IDH1 mutation status predicts VTE risk in patients with brain tumors
THROMB RES. 2018; 164: S195-S195.-9th International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC); APR 13-15, 2018; Bergamo, ITALY.
Doi: 10.1016/j.thromres.2018.02.038
[Oral Communication]
Web of Science
FullText
FullText_MUG